sb 203580 has been researched along with 4-hydroxy-2-hexenal in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (4-hydroxy-2-hexenal) | Trials (4-hydroxy-2-hexenal) | Recent Studies (post-2010) (4-hydroxy-2-hexenal) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 102 | 1 | 49 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, HY; Go, EK; Je, JH; Jung, KJ; Lee, JY; Sung, B; Yu, BP | 1 |
1 other study(ies) available for sb 203580 and 4-hydroxy-2-hexenal
Article | Year |
---|---|
NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway.
Topics: Aldehydes; Animals; Biological Transport; DNA-Binding Proteins; Endothelial Cells; Enzyme Inhibitors; Flavonoids; I-kappa B Kinase; Imidazoles; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; NF-kappaB-Inducing Kinase; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Prostate; Protein Serine-Threonine Kinases; Pyridines; Rats; Transcription Factor RelA; Transfection | 2004 |